364 related articles for article (PubMed ID: 31629940)
1. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
Yang M; Du Y; Chen H; Jiang D; Xu Z
Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
[TBL] [Abstract][Full Text] [Related]
2. Association between inhaled corticosteroids and upper respiratory tract infection in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
Chen H; Feng Y; Wang K; Yang J; Du Y
BMC Pulm Med; 2020 Oct; 20(1):282. PubMed ID: 33115481
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Spencer S; Evans DJ; Karner C; Cates CJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
[TBL] [Abstract][Full Text] [Related]
4. Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies.
Lodise TP; Li J; Gandhi HN; O'Brien G; Sethi S
Int J Chron Obstruct Pulmon Dis; 2020; 15():2889-2900. PubMed ID: 33204085
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids and the increased risk of pneumonia.
Marzoratti L; Iannella HA; Waterer GW
Ther Adv Respir Dis; 2013 Aug; 7(4):225-34. PubMed ID: 23445751
[TBL] [Abstract][Full Text] [Related]
6. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.
Wang CY; Lai CC; Yang WC; Lin CC; Chen L; Wang HC; Yu CJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2775-2783. PubMed ID: 27877031
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study.
Choi JH; Jeong KB; Park YH; Yu I; Lee SJ; Lee MK; Kim SH; Lee WY; Yong SJ; Lee JH
Int J Chron Obstruct Pulmon Dis; 2021; 16():3229-3237. PubMed ID: 34858023
[TBL] [Abstract][Full Text] [Related]
8. Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Peng S; Tan C; Du L; Niu Y; Liu X; Wang R
BMC Pulm Med; 2023 Aug; 23(1):304. PubMed ID: 37592316
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of inhaled corticosteroids and risk of upper respiratory tract infection in chronic obstructive pulmonary disease: a meta-analysis.
Yang M; Chen H; Zhang Y; Du Y; Xu Y; Jiang P; Xu Z
Inhal Toxicol; 2017 Apr; 29(5):219-226. PubMed ID: 28714745
[TBL] [Abstract][Full Text] [Related]
10. Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD: A Meta-analysis of 60 Randomized Controlled Trials.
Chen H; Deng ZX; Sun J; Huang Q; Huang L; He YH; Ma C; Wang K
Chest; 2023 Jan; 163(1):100-114. PubMed ID: 35921883
[TBL] [Abstract][Full Text] [Related]
11. Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
Morjaria JB; Rigby A; Morice AH
Lung; 2017 Jun; 195(3):281-288. PubMed ID: 28255905
[TBL] [Abstract][Full Text] [Related]
12. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
Kramer S; Rottier BL; Scholten RJ; Boluyt N
Cochrane Database Syst Rev; 2013 Feb; (2):CD010352. PubMed ID: 23450613
[TBL] [Abstract][Full Text] [Related]
13. Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis.
Pu X; Liu L; Feng B; Zhang Z; Wang G
Respir Res; 2021 Jul; 22(1):201. PubMed ID: 34238280
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis.
Tricco AC; Strifler L; Veroniki AA; Yazdi F; Khan PA; Scott A; Ng C; Antony J; Mrklas K; D'Souza J; Cardoso R; Straus SE
BMJ Open; 2015 Oct; 5(10):e009183. PubMed ID: 26503392
[TBL] [Abstract][Full Text] [Related]
15. Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies.
Loke YK; Cavallazzi R; Singh S
Thorax; 2011 Aug; 66(8):699-708. PubMed ID: 21602540
[TBL] [Abstract][Full Text] [Related]
16. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
17. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
[TBL] [Abstract][Full Text] [Related]
18. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.
Tashkin DP; Miravitlles M; Celli BR; Metzdorf N; Mueller A; Halpin DMG; Anzueto A
Respir Res; 2018 Oct; 19(1):196. PubMed ID: 30290801
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan.
Hirano R; Fujita M; Matsumoto T; On R; Watanabe K
Int J Chron Obstruct Pulmon Dis; 2018; 13():3503-3509. PubMed ID: 30498340
[TBL] [Abstract][Full Text] [Related]
20. Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials.
Chen H; Sun J; Huang Q; Liu Y; Yuan M; Ma C; Yan H
Front Pharmacol; 2021; 12():691621. PubMed ID: 34267661
[No Abstract] [Full Text] [Related]
[Next] [New Search]
